In contrast, a randomized intervention using 450–1300 mg/day of EPA + DHA for six months in children with NAFLD did not reduce the Alanine aminotransferase (ALT) liver enzyme levels (primary aim of the study), although a reduction in the aspartate aminotransferase (AST) liver enzyme level was achieved [112]. Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.